Novartis Investigative Site — Falls Church, Virginia

Novartis Investigative Site is a clinical research site located in Falls Church, Virginia, United States 22043.

Crixeo Health Trust Score: 70/100 (FAIR). This profile has not yet been claimed by the site owner.

Novartis Investigative Site has participated in 9 clinical trials with 1 currently active.

Therapeutic areas: Relapsing Multiple Sclerosis, Acute Heart Failure, Cardiovascular Disease and Lipoprotein(a).

Sponsors: Novartis Pharmaceuticals, Mereo BioPharma.

Sponsor Feasibility Report

Trust Score: 70/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Novartis Investigative Site?

Novartis Investigative Site has a Crixeo Trust Score of 70/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Novartis Investigative Site conducted?

Novartis Investigative Site has 9 clinical trials on record, with 1 currently active. Their work covers Relapsing Multiple Sclerosis, Acute Heart Failure, Cardiovascular Disease and Lipoprotein(a).

Is Novartis Investigative Site accredited by Crixeo Health?

Yes — Novartis Investigative Site holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Novartis Investigative Site?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.